Latest Asuragen Inc. Stories
Asuragen, Inc., announces that it has granted Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics, non-exclusive worldwide rights to incorporate Armored RNA(R) technology into its in vitro molecular diagnostics products.
Affymetrix Inc. (NASDAQ:AFFX) and Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to license, develop and manufacture in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications.
- Large; stout; burly.